Informing Patients About Drugs

Analysis of Alternative Designs for Erythromycin Leaflets

John D. Winkler, David E. Kanouse, Sandra H. Berry, Barbara Hayes-Roth, William H. Rogers, Jeffrey B. Garfinkle

ResearchPublished 1981

The research reported is the most thorough investigation to date on the effect of patient package inserts (PPIs). It represents a prospective study of the effects of various prototype PPIs on actual drug users. Drug information documents can vary radically in format, length, content, and style. To determine what type of document works best, it is desirable to conduct experiments that systematically vary such factors as the content, style, and format of the document while controlling for other factors. The research in this report applies such a strategy to study alternative leaflets for erythromycin, a commonly prescribed antibiotic used to treat infections. The results of three studies for this drug are presented, investigating the effects of six different structural variables: specificity of instructions, amount of explanation, writing style, risk emphasis, format, and reduced content (length). Also examined are the effects of receiving any PPI vs. receiving none.

Order a Print Copy

Format
Paperback
Page count
147 pages
List Price
$35.00
Buy link
Add to Cart

Document Details

  • Copyright: RAND Corporation
  • Availability: Available
  • Year: 1981
  • Print Format: Paperback
  • Paperback Pages: 147
  • Paperback Price: $35.00
  • Paperback ISBN/EAN: 978-0-8330-0349-2
  • Document Number: R-2798-FDA

Citation

RAND Style Manual
Winkler, John D., David E. Kanouse, Sandra H. Berry, Barbara Hayes-Roth, William H. Rogers, and Jeffrey B. Garfinkle, Informing Patients About Drugs: Analysis of Alternative Designs for Erythromycin Leaflets, RAND Corporation, R-2798-FDA, 1981. As of September 12, 2024: https://www.rand.org/pubs/reports/R2798.html
Chicago Manual of Style
Winkler, John D., David E. Kanouse, Sandra H. Berry, Barbara Hayes-Roth, William H. Rogers, and Jeffrey B. Garfinkle, Informing Patients About Drugs: Analysis of Alternative Designs for Erythromycin Leaflets. Santa Monica, CA: RAND Corporation, 1981. https://www.rand.org/pubs/reports/R2798.html. Also available in print form.
BibTeX RIS

This publication is part of the RAND report series. The report series, a product of RAND from 1948 to 1993, represented the principal publication documenting and transmitting RAND's major research findings and final research.

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.